← Eichor
Study identifier: NCT07325305 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes

Condition: Sarcopenia · Acute Lymphoblastic Leukemia  ·  Sponsor: Murdoch Childrens Research Institute

PhaseNA
Planned participants60
Who can joinAll sexes, 5 Years to 17 Years
Healthy volunteersNo

About this study

This is a small trial testing out a new approach before doing a bigger study. Researchers are observing a group of children/adolescents (ages 5-17) with acute lymphoblastic leukemia (ALL) and testing a physical activity and exercise program on a group of them who after 5 weeks of treatment show signs of weakness or frailty. Kids who are NOT losing muscle aren't part of the exercise trial - they're just monitored over time to see how they do. The goal: To see if an exercise program helps kids who are getting weaker from acute lymphoblastic leukemia treatment build back/maintain their strength, compared to kids who don't do the extra intervention. The study will also look at if this way of measuring muscle weakness works well for kids with cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Grimshaw, PhD Physiotherapy  ·  +61417162166  ·  sarah.grimshaw@mcri.edu.au

Ella Thorburn, Bachelor of Physiotherapy(hon)  ·  +61415066889  ·  ella.thorburn@student.unimelb.edu.au

Always discuss trial participation with your own doctor first.

Locations (1)

Royal Children's HospitalMelbourne, Victoria, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07325305